Men's Health Network Releases Statement in Support of New HPV Guidelines for Men

WASHINGTON, Oct. 25, 2011 /PRNewswire-USNewswire/ -- Men's Health Network Vice President Scott Williams released the following statement today, October 25, 2011, in support of the decision of the Advisory Committee on Immunization Practices of the CDC to recommend the vaccination of boys and young men against the human papillomavirus (HPV):

(Logo: http://photos.prnewswire.com/prnh/20100604/DC16079LOGO)

"Men's Health Network applauds today's decision by the advisory committee to recommend vaccination against HPV for boys and young men. This decision is a leap forward in protecting the health of men and boys and preventing cancer. HPV vaccination protects not just those who are vaccinated but also the health of their partners and the security of their families.

"But we need to go further. Existing prevention recommendations under the Affordable Care Act provide for Chlamydia and Gonorrhea screenings for women, but not men. Combating these diseases requires the screening and treatment of both, and Men's Health Network calls for new federal guidelines to address this issue. You cannot stop the spread of these diseases if you only address one side of the equation."

Men's Health Network's proposed guidelines for men's preventative services can be found here: http://www.menshealthnetwork.org/library/HELPPreventionMHNstatement101211.pdf

SOURCE Men's Health Network

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.